Evidence map›Paper›PMID 42262503›Full record

ArticleAnnals of African medicine2026

Activation of the Nuclear Factor Kappa-light-chain-enhancer of Activated B-cells Pathway Induces a Pro-inflammatory Network in Patients with Pulmonary Tuberculosis.

Vanitha Gnanasoundran, Suganya Kannan, Jeyakumar Balakrishnan

Abstract read
In one paragraph

Article in Annals of African medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vanitha GnanasoundranDepartment of Respiratory Medicine, Vinayaka Mission's Medical College and Hospital, Vinayaka Mission's Research Foundation (Deemed to be University), Puducherry, India.
Suganya KannanCentral Research Laboratory for Biomedical Research, Vinayaka Mission's Medical College and Hospital, Vinayaka Mission's Research Foundation (Deemed to be University), Puducherry, India.
Jeyakumar BalakrishnanCentral Research Laboratory for Biomedical Research, Vinayaka Mission's Medical College and Hospital, Vinayaka Mission's Research Foundation (Deemed to be University), Puducherry, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeukocyte-stimulating inflammatory cytokines, including interleukin (IL)-27, IL-1β, and IL-10, in conjunction with the transcription factor nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-κB), are essential in limiting Mycobacterium tuberculosis infections; however, it remains uncertain if these indicators are a reliable indicator of the severity of TB illness. MATERIALS AND

methodsUsing real-time polymerase chain reaction (PCR), we examined the mRNA expression of IL-27, IL-1β, IL-10, and NF-κB in peripheral blood mononuclear cell responses in patients with tuberculosis (TB) ( n = 25).

resultsPCR amplification of 16S specific to mycobacterium DNA showed 84% positivity rate among the 25 samples. Sputum patients with active TB showed higher activation NF-κB mRNA expression when compared to healthy controls. Furthermore, the multidimensional IL-27 secretion in TB patients showed statistically significant mRNA expression as compared to healthy controls. Similarly, TB patients had drastically changed pro-inflammatory cytokine IL-1β mRNA expression. In addition, TB patients' anti-inflammatory cytokine IL-10 mRNA expression was substantially lower than that of healthy controls.

conclusionOur findings highlight significant alterations in cytokine expression (IL-27, IL-1β, and IL-10) and NF-κB activation in active TB patients, indicating their potential roles in TB pathogenesis. However, further research is required to confirm their value as biomarkers for disease severity.

Indexed as

Leukocytes, MononuclearMycobacterium tuberculosisNF-kappa BTuberculosis, PulmonaryAdultCase-Control StudiesCytokinesFemaleHumansInterleukin-10Interleukin-1betaMaleMiddle AgedReal-Time Polymerase Chain ReactionRNA, MessengerSeverity of Illness IndexCytokinesInterleukin-10Interleukin-1betaNF-kappa BRNA, MessengerActive tuberculosisexpression géniquefacteur nucléaire kappa-light-chain-enhancer des cellules B activéesgene expressioninflammatory markersinterleukin-27interleukine-27marqueurs inflammatoiresnuclear factor kappa-light-chain-enhancer of activated B-cellspro-inflammatoirepro-inflammatoryTuberculose active

Identifiers

PMID42262503
PMCPMC13645281

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.